Catalyst
Pit
Terminal
Pit Consensus
Insiders
Politicians
Institutions
News
Screener
More ▾
Terminal
Pit Consensus
Insiders
Politicians
Institutions
News
Screener
More ▾
☰
INKT
MiNK Therapeutics, Inc.
NASDAQ · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Last close
$12.55
· 2026-09-30
ABOUT
Exchange
NASDAQ
Sector
Healthcare
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Market cap
$64.04M
Country
USA
RECENT INSIDER TRADES
2026-09-02
· Corvese Brian
(Director)
· OTHER
2026-09-02
· Behner Peter
(Director)
· OTHER
2026-09-02
· WIINBERG ULF
(Director)
· OTHER
2026-09-02
· Ryan Barbara
(Director)
· OTHER
2026-09-02
· Holcomb John Bradley
(Director)
· OTHER
INSTITUTIONAL OWNERSHIP
Institutional holders
29
Shares held
359,270
Value
$3.23M
Percent of shares outstanding
7.04%
As of quarter end
2026-06-30
RECENT NEWS
Mink Ventures Corporation Completes Drill Program at Rankin Property
MiNK Therapeutics to present colorectal cancer data at SITC 2026
MiNK Therapeutics Selected for ARPA-H-Funded Initiative to Advance Room-Temperature Cell Therapy
Catalyst
Pit
Features
Coming soon
Pricing
Coming soon
Privacy
Terms
Disclaimer
Affiliate Terms
Contact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS